Middle East & Africa Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Material (Glass Prefilled Syringes and Plastic Prefilled Syringes), Design (Single Chamber and Multi-chamber), Application (Cancer, Diabetes, Autoimmune Disease, Infectious diseases, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel)
The Middle East & Africa prefilled syringe market was valued at US$ 202.76 million in 2022 and is expected to reach US$ 404.57 million by 2030; it is estimated to grow at a CAGR of 9.0% from 2022 to 2030.
Ongoing Innovation in Prefilled Syringes Drive Middle East & Africa Prefilled Syringe Market
Over a period of time, various aspects of the healthcare industry have been developed to simplify the working process of healthcare professionals and enhance the quality of care by ensuring the safety of patients and healthcare providers. The prefilled syringes have undergone several innovation updates and developments to provide comfort and safety along with a reduction in biomedical waste. Some of the innovations made by manufacturers in prefilled syringes are mentioned below:
• West Pharmaceutical Services provides line extensions that include insert needle syringes and more needle sizes with product volume options. In the past three to five years, there have been more approvals in the larger 2.5-ml format. The larger volume reduces the amount of syringes needed per dose and enhances efficiency and comfort. There is a growing trend of finer needles too; smaller, thinner needles mean less pain.
• Prefilled syringes provide sustainability benefits by reducing multi-dose vials and related production and handling, along with product waste associated with leftover products. There is a lot of room for improvement as the current systems create a lot of waste, owing to which attempts are being made to reduce scrap rates and reuse the tubs that hold nested containers through the fill-finish process.
• Suppliers are looking for designs to prevent needlestick injuries, protect product quality by minimizing particulates, and eliminate product interaction with tungsten or silicone residues. Gerresheimer Biological Solutions provides metal-free syringes manufactured from tungsten-sensitive products. With this patented technology, the pin meant for conical shaping is made of a ceramic rather than tungsten or other metal.
• Silicone oil is commonly used to enhance syringe performance, but it can cause aggregation and particulate issues for sensitive biologicals. The ophthalmologists and regulatory bodies are urging them to move away from siliconized formats. Some patients experience reactions to silicone, and over time, with repeated injections, the material can become accumulated. One silicone-free option is paired with ImproJect plungers from W.L. Gore & Associates and SCHOTT BioPure silicone-free syringes from SCHOTT. This system opens the door for many sensitive products to enter the prefilled syringe format. Thorough attention to syringe geometry and dimensions of the syriQ BioPure syringes helps ensure a constant gliding force and injection duration over the shelf-life of the product and upholds container closure integrity without the use of silicone. Minimal cannula adhesive and ultra-low tungsten residuals reduce the extractible profile and the potential for container and drug interactions.
COVID-19 has increased the development of prefilled syringes, particularly with regard to low-temperature storage. As of now, all COVID-19 vaccines are available in vials, but in the next two to four years, it is expected to be available in novel type of syringe that handles ?80?C.
Therefore, increasing innovations in the prefilled syringes are expected to promote the growth of the prefilled syringes market in the near future
Middle East & Africa Prefilled Syringe Market Overview
The Middle East & Africa prefilled syringes market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. The market growth in this region is attributed to the increasing incidence of diabetes, infertility, and other chronic diseases, which triggered several companies to focus on product development, i.e., prefilled syringes.
Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are a few of the major countries in the Rest of Middle East & Africa. According to the National Library of Medicine (NLM), ~415,800 adults in Israel had diabetes in 2022, which is 8.1% of the adult population. According to the Health Research Policy and Systems in 2020, the prevalence of infertility in Iran ranges from 10.3% to 24.9%. Moreover, an increase in product launches in prefilled syringe format for the treatment of chronic disorders is expected to promote the market growth. For instance, in February 2023, Teva Neuroscience, Inc. Israel, started the marketing of COPAXONE for treating multiple sclerosis by using prefilled syringe. Thus, the growing number of diabetes, infertility cases and other chronic disorders, along with frequent product launches, are the factors bolstering the growth of the prefilled syringe market in the Rest of Middle East & Africa.
Middle East & Africa Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Prefilled Syringe Market Segmentation
The Middle East & Africa prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.
Based on type, the Middle East & Africa prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Middle East & Africa prefilled syringe market share in 2022.
Based on material, the Middle East & Africa prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Middle East & Africa prefilled syringe share in 2022.
Based on designs, the Middle East & Africa prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Middle East & Africa prefilled syringe share in 2022.
In terms of application, the Middle East & Africa prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Middle East & Africa prefilled syringe share in 2022.
By distribution channel, the Middle East & Africa prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Middle East & Africa prefilled syringe market share in 2022.
Based on country, the Middle East & Africa prefilled syringe market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa prefilled syringe market in 2022.
B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Middle East & Africa prefilled syringe market.
Ongoing Innovation in Prefilled Syringes Drive Middle East & Africa Prefilled Syringe Market
Over a period of time, various aspects of the healthcare industry have been developed to simplify the working process of healthcare professionals and enhance the quality of care by ensuring the safety of patients and healthcare providers. The prefilled syringes have undergone several innovation updates and developments to provide comfort and safety along with a reduction in biomedical waste. Some of the innovations made by manufacturers in prefilled syringes are mentioned below:
• West Pharmaceutical Services provides line extensions that include insert needle syringes and more needle sizes with product volume options. In the past three to five years, there have been more approvals in the larger 2.5-ml format. The larger volume reduces the amount of syringes needed per dose and enhances efficiency and comfort. There is a growing trend of finer needles too; smaller, thinner needles mean less pain.
• Prefilled syringes provide sustainability benefits by reducing multi-dose vials and related production and handling, along with product waste associated with leftover products. There is a lot of room for improvement as the current systems create a lot of waste, owing to which attempts are being made to reduce scrap rates and reuse the tubs that hold nested containers through the fill-finish process.
• Suppliers are looking for designs to prevent needlestick injuries, protect product quality by minimizing particulates, and eliminate product interaction with tungsten or silicone residues. Gerresheimer Biological Solutions provides metal-free syringes manufactured from tungsten-sensitive products. With this patented technology, the pin meant for conical shaping is made of a ceramic rather than tungsten or other metal.
• Silicone oil is commonly used to enhance syringe performance, but it can cause aggregation and particulate issues for sensitive biologicals. The ophthalmologists and regulatory bodies are urging them to move away from siliconized formats. Some patients experience reactions to silicone, and over time, with repeated injections, the material can become accumulated. One silicone-free option is paired with ImproJect plungers from W.L. Gore & Associates and SCHOTT BioPure silicone-free syringes from SCHOTT. This system opens the door for many sensitive products to enter the prefilled syringe format. Thorough attention to syringe geometry and dimensions of the syriQ BioPure syringes helps ensure a constant gliding force and injection duration over the shelf-life of the product and upholds container closure integrity without the use of silicone. Minimal cannula adhesive and ultra-low tungsten residuals reduce the extractible profile and the potential for container and drug interactions.
COVID-19 has increased the development of prefilled syringes, particularly with regard to low-temperature storage. As of now, all COVID-19 vaccines are available in vials, but in the next two to four years, it is expected to be available in novel type of syringe that handles ?80?C.
Therefore, increasing innovations in the prefilled syringes are expected to promote the growth of the prefilled syringes market in the near future
Middle East & Africa Prefilled Syringe Market Overview
The Middle East & Africa prefilled syringes market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. The market growth in this region is attributed to the increasing incidence of diabetes, infertility, and other chronic diseases, which triggered several companies to focus on product development, i.e., prefilled syringes.
Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are a few of the major countries in the Rest of Middle East & Africa. According to the National Library of Medicine (NLM), ~415,800 adults in Israel had diabetes in 2022, which is 8.1% of the adult population. According to the Health Research Policy and Systems in 2020, the prevalence of infertility in Iran ranges from 10.3% to 24.9%. Moreover, an increase in product launches in prefilled syringe format for the treatment of chronic disorders is expected to promote the market growth. For instance, in February 2023, Teva Neuroscience, Inc. Israel, started the marketing of COPAXONE for treating multiple sclerosis by using prefilled syringe. Thus, the growing number of diabetes, infertility cases and other chronic disorders, along with frequent product launches, are the factors bolstering the growth of the prefilled syringe market in the Rest of Middle East & Africa.
Middle East & Africa Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Prefilled Syringe Market Segmentation
The Middle East & Africa prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.
Based on type, the Middle East & Africa prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Middle East & Africa prefilled syringe market share in 2022.
Based on material, the Middle East & Africa prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Middle East & Africa prefilled syringe share in 2022.
Based on designs, the Middle East & Africa prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Middle East & Africa prefilled syringe share in 2022.
In terms of application, the Middle East & Africa prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Middle East & Africa prefilled syringe share in 2022.
By distribution channel, the Middle East & Africa prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Middle East & Africa prefilled syringe market share in 2022.
Based on country, the Middle East & Africa prefilled syringe market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa prefilled syringe market in 2022.
B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Middle East & Africa prefilled syringe market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Disorders
4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
4.2.1 Increasing Product Recalls
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis
5. PREFILLED SYRINGE MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
5.1 Middle East & Africa Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030
6. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY TYPE
6.1 Overview
6.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
6.3.1 Overview
6.3.2 Disposable Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
6.4.1 Overview
6.4.2 Reusable Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY MATERIAL
7.1 Overview
7.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
7.3.1 Overview
7.3.2 Glass Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
7.4.1 Overview
7.4.2 Plastic Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DESIGN
8.1 Overview
8.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
8.3.1 Overview
8.3.2 Single Chamber: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
8.4.1 Overview
8.4.2 Multi-chamber: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
9.1 Overview
9.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
9.3.1 Overview
9.3.2 Cancer: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
9.6.1 Overview
9.6.2 Infectious Diseases: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DISTRIBUTION CHANNEL
10.1 Overview
10.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Hospital Pharmacies: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Retail Pharmacies: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
11. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - COUNTRY ANALYSIS
11.1 Middle East & Africa Prefilled Syringes Market, Revenue and Forecast to 2030
11.1.1 Middle East & Africa Prefilled Syringes Market, by Country
11.1.1.1 UAE
11.1.1.1.1 Overview
11.1.1.1.2 UAE Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 UAE: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.1.4 UAE: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.1.5 UAE: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.1.6 UAE: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.1.7 UAE: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.1.2 Saudi Arabia
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Saudi Arabia: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.2.4 Saudi Arabia: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.2.5 Saudi Arabia: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.2.6 Saudi Arabia: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.7 Saudi Arabia: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.1.3 South Africa
11.1.1.3.1 Overview
11.1.1.3.2 South Africa Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 South Africa: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.3.4 South Africa: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.3.5 South Africa: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.3.6 South Africa: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.7 South Africa: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.1.4 Rest of Middle East & Africa
11.1.1.4.1 Rest of Middle East & Africa Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Rest of Middle East & Africa: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.4.3 Rest of Middle East & Africa: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.4.4 Rest of Middle East & Africa: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.4.5 Rest of Middle East & Africa: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.4.6 Rest of Middle East & Africa: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 B Braun SE
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Shandong Weigao Group Medical Polymer Co Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Schott AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Nipro Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Becton Dickinson and Co
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Baxter International Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Terumo Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Ypsomed Holding AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Disorders
4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
4.2.1 Increasing Product Recalls
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis
5. PREFILLED SYRINGE MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
5.1 Middle East & Africa Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030
6. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY TYPE
6.1 Overview
6.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
6.3.1 Overview
6.3.2 Disposable Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
6.4.1 Overview
6.4.2 Reusable Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY MATERIAL
7.1 Overview
7.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
7.3.1 Overview
7.3.2 Glass Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
7.4.1 Overview
7.4.2 Plastic Prefilled Syringes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DESIGN
8.1 Overview
8.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
8.3.1 Overview
8.3.2 Single Chamber: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
8.4.1 Overview
8.4.2 Multi-chamber: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
9.1 Overview
9.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
9.3.1 Overview
9.3.2 Cancer: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
9.6.1 Overview
9.6.2 Infectious Diseases: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DISTRIBUTION CHANNEL
10.1 Overview
10.2 Middle East & Africa Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Hospital Pharmacies: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Retail Pharmacies: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: Middle East & Africa Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
11. MIDDLE EAST & AFRICA PREFILLED SYRINGE MARKET - COUNTRY ANALYSIS
11.1 Middle East & Africa Prefilled Syringes Market, Revenue and Forecast to 2030
11.1.1 Middle East & Africa Prefilled Syringes Market, by Country
11.1.1.1 UAE
11.1.1.1.1 Overview
11.1.1.1.2 UAE Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 UAE: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.1.4 UAE: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.1.5 UAE: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.1.6 UAE: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.1.7 UAE: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.1.2 Saudi Arabia
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Saudi Arabia: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.2.4 Saudi Arabia: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.2.5 Saudi Arabia: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.2.6 Saudi Arabia: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.7 Saudi Arabia: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.1.3 South Africa
11.1.1.3.1 Overview
11.1.1.3.2 South Africa Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 South Africa: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.3.4 South Africa: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.3.5 South Africa: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.3.6 South Africa: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.7 South Africa: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.1.4 Rest of Middle East & Africa
11.1.1.4.1 Rest of Middle East & Africa Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Rest of Middle East & Africa: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.1.4.3 Rest of Middle East & Africa: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.1.4.4 Rest of Middle East & Africa: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.1.4.5 Rest of Middle East & Africa: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.1.4.6 Rest of Middle East & Africa: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 B Braun SE
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Shandong Weigao Group Medical Polymer Co Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Schott AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Nipro Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Becton Dickinson and Co
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Baxter International Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Terumo Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Ypsomed Holding AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Prefilled Syringe Market Segmentation
Table 2. UAE Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. UAE Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 4. UAE Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 5. UAE Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, Prefilled Syringe Market
Table 1. Middle East & Africa Prefilled Syringe Market Segmentation
Table 2. UAE Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. UAE Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 4. UAE Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 5. UAE Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 22. Organic Developments Done by Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms, Prefilled Syringe Market
